BMJ5mon
Efficacy of prednisone 1–4 mg/day in patients with rheumatoid arthritis: a randomised, double-blind, placebo controlled withdrawal clinical trial
The protocol included three phases: (1) equivalence: 1–4 study prednisone 1 mg tablets taken for 12 weeks to ascertain their efficacy compared with the patient’s usual tablets before randomisation; (2 ...
BMJ6mon
Glucocorticoids for acute urticaria: study protocol for a double-blind non-inferiority randomised controlled trial
In ED: placebo of prednisone 1 mg/kg once orally, without exceeding a maximum of six tablets. At home: placebo of prednisone 40 mg (two tablets) once per day for 3 days orally. In ED: prednisone 20 mg ...
rmdopen.bmj21d
Modified-release prednisone for polymyalgia rheumatica: a multicentre, randomised, active-controlled, double-blind, parallel-group study
Preliminary studies suggest that MR prednisone may also have benefits in polymyalgia ... and cessation of production of the comparator Decortin 1 mg tablets, led to the premature termination of the ...